Xenorphen on EU
![]() | VI | 111 | 43.24% | 678 | 544 | 178 | 0.52 | 34.23% | — | — | −23% | |||
![]() | V | 100 | 53.00% | 706 | 384 | 153 | 0.67 | 32.00% | — | −4% | ||||
![]() | VIII | 98 | 33.67% | 317 | 506 | 272 | 0.32 | 26.53% | — | — | −50% | |||
![]() | V | 86 | 41.86% | 524 | 280 | 117 | 0.51 | 34.88% | — | — | −15% | |||
![]() | V | 73 | 43.84% | 563 | 293 | 132 | 0.60 | 30.14% | — | — | −16% | |||
![]() | IV | 66 | 48.48% | 89 | 75 | 78 | 0.12 | 22.73% | — | — | −69% | |||
![]() | V | 64 | 39.06% | 589 | 370 | 69 | 0.59 | 29.69% | — | — | −10% | |||
![]() | V | 64 | 54.69% | 551 | 201 | 126 | 0.53 | 29.69% | — | — | −18% | |||
![]() | V | 64 | 51.56% | 493 | 286 | 45 | 0.55 | 35.94% | — | — | −42% | |||
![]() | VI | 59 | 50.85% | 403 | 194 | 273 | 0.46 | 18.64% | — | — | −41% | |||
![]() | VI | 58 | 39.66% | 650 | 533 | 76 | 0.69 | 25.86% | — | — | −28% | |||
![]() | VI | 57 | 36.84% | 190 | 283 | 120 | 0.39 | 22.81% | — | — | −54% | |||
![]() | IV | 57 | 43.86% | 112 | 96 | 100 | 0.19 | 26.32% | — | — | −61% | |||
![]() | IV | 51 | 58.82% | 974 | 301 | 67 | 0.73 | 39.22% | — | — | +4% | |||
![]() | V | 45 | 53.33% | 854 | 468 | 111 | 0.87 | 40.00% | — | — | −14% | |||
![]() | V | 42 | 45.24% | 407 | 180 | 139 | 0.76 | 16.67% | — | — | +2% | |||
![]() | IV | 40 | 47.50% | 451 | 208 | 51 | 0.42 | 30.00% | — | — | −5% | |||
![]() | IV | 39 | 43.59% | 253 | 189 | 44 | 0.51 | 20.51% | — | — | −49% | |||
![]() | IV | 38 | 42.11% | 541 | 286 | 37 | 0.79 | 31.58% | — | — | −2% | |||
![]() | IV | 37 | 62.16% | 440 | 177 | 110 | 0.24 | 24.32% | — | — | +24% | |||
![]() | IV | 33 | 54.55% | 468 | 193 | 63 | 0.30 | 18.18% | — | — | −13% | |||
![]() | III | 32 | 56.25% | 286 | 100 | 91 | 0.41 | 18.75% | — | — | −41% | |||
![]() | IV | 28 | 53.57% | 561 | 233 | 61 | 0.61 | 25.00% | — | — | −38% | |||
![]() | IV | 26 | 50.00% | 168 | 105 | 69 | 0.27 | 34.62% | — | — | −47% | |||
![]() | II | 25 | 56.00% | 205 | 78 | 26 | 0.48 | 36.00% | — | — | −58% |